K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 5.8 CAD -0.34% Market Closed
Market Cap: CA$575.9m

Profitability Summary

Knight Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Knight Therapeutics Inc

Margins Comparison
Knight Therapeutics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
Knight Therapeutics Inc
TSX:GUD
578.1m CAD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.9B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
208.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.3B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.2B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Knight Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Knight Therapeutics Inc
TSX:GUD
578.1m CAD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
275.9B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
208.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.3B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
94.2B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Knight Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate